medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2009, Number 1

<< Back Next >>

Rev Mex Oftalmol 2009; 83 (1)

Atención médica y oftalmológica de una población diabética previo a su ingreso a un centro oftalmológico de referencia

Favier-González C, Lesso-Zamora J, Sáenz VSM

Language: Spanish
References: 12
Page: 15-17
PDF size: 75.88 Kb.


ABSTRACT

Objective: To know the type and ophthalmologic attention received by a population with diabetes previous to its entrance in an ophthalmologic center of reference.
Material and methods: Observational prospective study made by means of questionnaire to patients with diabetes mellitus type 2, between August 2007 and February 2008 in the Mexican Institute of Ophthalmology.
Results: 220 patients were included. Mean age was 58.5 years, being 51% in productive age, 46% have more than 10 years with diabetes, 32% resorted to the alternative medicine, leaving their allopathic treatment, 38% do not refer medical supervision of their metabolic control on the past three months and 62% never had consulted the ophthalmologist contrasting with 65% that received optometrist evaluation of their visual problems. Only 15% were referred to the ophthalmologist by doctors and 6% by optometrists.
Conclusion: Diabetic metabolic control by doctors is irregular. One third resorts to traditional medicine, two third parts looks for ophthalmologic attention in optical services. Few optometrists and doctors refer patients to the ophthalmologist.


REFERENCES

  1. Arredondo A, Zuñiga A. Economic consequences of epidemiological changes in diabetes in middle-income countries. Diabetes Care 2004; 27(1):104-109.

  2. Rull JA, Aguilar-Salinas C, Rojass R y cols. Epidemiology of type 2 diabetes in Mexico. Arch Med Research 2005; 36(3):188-196.

  3. Lerman GI. La atención del paciente más allá del primer nivel de atención. Salud Pública de México 2007; 49:99-103.

  4. Aguilar-Salinas C, Velásquez-Monroy O, Gómez-Pérez F y cols. Characteristics of the patients with type 2 diabetes in Mexico: Results from a large population-based, nationwide survey. Diabetes Care 2003; 26(7):2021-2026.

  5. SSA. Programa de acción: Diabetes Mellitus. 1a ed. México, DF. Secretaría de Salud; 2001.

  6. Secretaria de Salud. Mortalidad 2001 en México. Salud Pública 2002; 44:571-578.

  7. Mukamel DB, Bresnick GH, Wang Q y cols. Barriers to compliance with screening guidelines for diabetic retinopathy. Ophthalmic Epidemiol 1999; 6:61-72.

  8. Rodríguez-Villalobos E, Cervantes-Aguayo F, Vargas-Salado E y cols. Retinopatía diabética. Incidencia y progresión a 12 años. Cirugía y Cirujanos 2005; 73(2):79-84.

  9. Dodson PM. Diabetic retinopathy: treatment and prevention. Diabetes Vascular Disease Research 2007; 4(3): 9-11.

  10. Gregory AN, Brown JB. Unadjusted and Adjusted Prevalence of Diagnosed Depression in Type 2 Diabetes. Diabetes Care 2003; 26(3):744-749.

  11. Saucedo MT , Bañuelos FM, Cabrera PR y cols. La práctica de la medicina alternativa: una realidad en el paciente diabético en Hermosillo, Son., México. Rev Salud Pública y Nutrición 2006; 7(4).

  12. Características de las personas con discapacidad visual. Fuente: URL: http: //www.inegi.gob.mx




2020     |     www.medigraphic.com